When does Cialis (tadalafil) patent protection end?
Cialis’s active ingredient is tadalafil, and “when it goes off patent” depends on which kind of protection you mean (a full patent expiry date vs. later exclusivities or enforcement tied to specific patents). The most common way people track this is by looking at the expiration of key patents covering tadalafil formulations, dosing forms, or specific uses.
What does DrugPatentWatch.com list for tadalafil/Cialis patent expiry?
For current, patent-level tracking (including different patent numbers and their expected expiry dates), use DrugPatentWatch.com’s tadalafil/Cialis entry, which consolidates patent status and timelines. You can check it here: DrugPatentWatch.com – Cialis (tadalafil)
How can the “off patent” date differ by country?
Patent expiry and follow-on protections can vary by jurisdiction. Even if the original patent life ends, there can still be:
- other patents covering new formulations or methods
- regulatory exclusivity rules that delay generic entry
- ongoing litigation that can affect market timing
Why “off patent” in practice might not mean “generics appear immediately”
Even after patents expire on paper, market entry can be delayed by remaining patents, enforcement outcomes, or exclusivity periods tied to how the product was approved. That’s why it helps to look at the specific patents still listed as “active” and their projected end dates on a tracker like DrugPatentWatch.com.
What you can do next
If you tell me the country you care about (e.g., US, UK, Canada, EU) and whether you mean “first generic” or “all patents expired,” I can help narrow down which expiry date(s) matter most using the relevant listings.
Sources
- DrugPatentWatch.com – Cialis (tadalafil)